BRUKER CORPORATION Finance Lease, Right-of-Use Asset, Amortization
BRUKER CORPORATION (BRKR) reported Finance Lease, Right-of-Use Asset, Amortization of $5.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-27
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $100.00K.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $100.00K.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $100.00K.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for fiscal 2025 was $5.20M, a 13.04% increase from fiscal 2024.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for fiscal 2024 was $4.60M, a 12.20% increase from fiscal 2023.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for fiscal 2023 was $4.10M, a 24.24% increase from fiscal 2022.
- BRUKER CORPORATION finance lease, right-of-use asset, amortization for fiscal 2022 was $3.30M, a 120.00% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.20M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $4.60M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $4.10M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $3.30M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $1.50M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $700.00K 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $200.00K derived: sum of 2 quarters · filed 2022-02-28 | $300.00K derived: sum of 3 quarters · filed 2022-02-28 | $300.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-04 | $200.00K derived: sum of 2 quarters · filed 2019-11-04 | $200.00K 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-09 | $100.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |